Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms
Stefano Comai(University of Padua), Gabriella Gobbi(McGill University), Eugenio Ragazzi(University of Padua), Garrett Sauber(Medical College of Wisconsin), Maykel F. Ghabrash(McGill University Health Centre), Allan Fielding(McGill University Health Centre), Nancy Low(McGill University), Cecilia J. Hillard(Medical College of Wisconsin), Nicolás A. Núñez(Mayo Clinic), Marie Saint-Laurent(McGill University Health Centre), Rita Zakarian(McGill University), Tobias Atkin(McGill University)
Cited by 17
Related Papers
Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood
|JAMA Psychiatry|2019|911
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
|Proceedings of the National Academy of Sciences|2005|677
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?
|Neuropsychopharmacology|2017|450
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
|Pharmacological Reviews|2018|386